Mutual of America Capital Management LLC increased its stake in shares of Medifast, Inc. (NYSE:MED – Get Rating) by 5.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,673 shares of the specialty retailer’s stock after acquiring an additional 85 shares during the period. Mutual of America Capital Management LLC’s holdings in Medifast were worth $286,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. Gladius Capital Management LP bought a new stake in Medifast during the fourth quarter worth about $96,000. Islay Capital Management LLC acquired a new position in Medifast during the fourth quarter worth approximately $133,000. PEAK6 Investments LLC increased its position in Medifast by 111.9% during the fourth quarter. PEAK6 Investments LLC now owns 959 shares of the specialty retailer’s stock worth $201,000 after buying an additional 9,015 shares during the last quarter. Steward Partners Investment Advisory LLC increased its position in Medifast by 14.7% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,378 shares of the specialty retailer’s stock worth $289,000 after buying an additional 177 shares during the last quarter. Finally, Inspire Investing LLC acquired a new position in Medifast during the first quarter worth approximately $237,000. Institutional investors own 84.78% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on MED shares. StockNews.com raised Medifast from a “hold” rating to a “buy” rating in a research report on Saturday. DA Davidson boosted their price target on Medifast from $341.00 to $352.00 and gave the stock a “buy” rating in a research report on Thursday, June 2nd.
Medifast Trading Up 4.4 %
Medifast stock opened at $175.61 on Tuesday. Medifast, Inc. has a 12 month low of $154.67 and a 12 month high of $295.38. The stock’s 50 day moving average is $177.77 and its 200-day moving average is $180.67. The company has a market capitalization of $2.02 billion, a price-to-earnings ratio of 12.53 and a beta of 1.08.
Medifast (NYSE:MED – Get Rating) last posted its earnings results on Monday, May 2nd. The specialty retailer reported $3.59 EPS for the quarter, beating the consensus estimate of $3.56 by $0.03. Medifast had a return on equity of 81.42% and a net margin of 10.28%. The company had revenue of $417.60 million for the quarter, compared to the consensus estimate of $415.20 million. As a group, equities research analysts predict that Medifast, Inc. will post 15.74 earnings per share for the current fiscal year.
Medifast Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, August 8th. Stockholders of record on Tuesday, June 28th will be given a $1.64 dividend. This represents a $6.56 annualized dividend and a dividend yield of 3.74%. The ex-dividend date is Monday, June 27th. Medifast’s payout ratio is 46.79%.
Medifast Company Profile
Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
- Get a free copy of the StockNews.com research report on Medifast (MED)
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- Deep Value High Yield Newell Brands Is Ready To Bottom
- The Colgate-Palmolive Growth Outlook Brightens
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.